Vectorite Biomedical Inc.
4170
Rank in Stocks
#27613
Vectorite Biomedical Inc., established in 1993 and based in New Taipei City,... Vectorite Biomedical Inc., established in 1993 and based in New Taipei City, Taiwan, is a biotechnology firm dedicated to research and development activities globally, including a strong presence in its home country. The company's operations encompass the manufacturing of specialized cell preparation products, in addition to providing full-spectrum services for the collection, processing, and secure storage management of immune cells. These advanced cellular preparations are vital for applications in the medical fields of infectious diseases, inflammatory conditions, and various oncological and tumor-related illnesses.
Share Price
$0.32618371
Last synced: 2026-11-10
Market Cap
$14.28M
Change (1 day)
-2.28%
Change (1 year)
-28.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vectorite Biomedical Inc. (4170)
Category
Healthcare
Operating Margin for Vectorite Biomedical Inc. (4170)
Operating Margin as of November 2026 TTM: -42.29%
According to Vectorite Biomedical Inc.'s latest financial reports, its current operating margin (TTM) is -42.29%. At the end of 2025 the company had an operating margin of -35.68%.
Operating Margin history for Vectorite Biomedical Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -42.29% | 18.53% |
| 2025 | -35.68% | -20.64% |
| 2024 | -44.96% | 55.68% |
| 2023 | -28.88% | -140.58% |
| 2022 | 71.16% | -148.30% |
| 2021 | -147.34% | -40.65% |
| 2020 | -248.24% | -33.84% |
| 2019 | -375.19% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.91% |
US
|
|
| -149.01% | -96.48% |
US
|
|
| 25.57% | -100.60% |
AU
|
|
| 31.23% | -100.74% |
BE
|
|
| 29.35% | -100.69% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Vectorite Biomedical Inc.'s operating margin
What is Vectorite Biomedical Inc.'s operating margin?
Vectorite Biomedical Inc.'s operating margin is -42.29%, as of Nov 2026.
What was Vectorite Biomedical Inc.'s operating margin in 2025?
In 2025, Vectorite Biomedical Inc.'s operating margin was -35.68%, compared with -44.96% in 2024.
How has Vectorite Biomedical Inc.'s operating margin changed since 2020?
From 2020 to 2025, Vectorite Biomedical Inc.'s operating margin was highest in 2022 (71.16%) and lowest in 2020 (-248.24%).
How does Vectorite Biomedical Inc.'s operating margin compare with similar companies?
Vectorite Biomedical Inc.'s operating margin (-42.29%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.